Back to Search
Start Over
Predicting outcomes in hyperthyroid cats treated with radioiodine.
- Source :
-
Journal of veterinary internal medicine [J Vet Intern Med] 2022 Jan; Vol. 36 (1), pp. 49-58. Date of Electronic Publication: 2021 Nov 24. - Publication Year :
- 2022
-
Abstract
- Background: Radioiodine ( <superscript>131</superscript> I) is the treatment of choice for cats with hyperthyroidism. After <superscript>131</superscript> I, however, euthyroidism is not always achieved, with 5% to 10% of cats remaining persistently hyperthyroid and 20% to 50% developing iatrogenic hypothyroidism.<br />Objectives: To identify pretreatment factors that may help predict persistent hyperthyroidism and iatrogenic hypothyroidism after treatment of cats using a novel <superscript>131</superscript> I dosing algorithm.<br />Animals: One thousand and four hundred hyperthyroid cats treated with <superscript>131</superscript> I.<br />Methods: Prospective, before-and-after study. Pretreatment predictors (clinical, laboratory, scintigraphic, <superscript>131</superscript> I dose, <superscript>131</superscript> I uptake measurements) of treatment failure or iatrogenic hypothyroidism were identified by multivariable logistic regression analysis.<br />Results: Cats that developed iatrogenic hypothyroidism were more likely to be older (odds ratio [OR] = 1.10; 95% confidence interval [CI], 1.04-1.17; P = .001), female (OR = 2.04; 95% CI, 1.54-2.70; P < .001), have detectable serum thyroid-stimulating hormone (TSH) concentrations (OR = 4.19; 95% CI, 2.0-8.81; P < .001), have bilateral thyroid nodules (OR = 1.57; 95% CI, 1.19-2.08; P < .001), have homogeneous, bilateral distribution of <superscript>99m</superscript> Tc-pertechnetate uptake (OR = 2.93; 95% CI, 2.05-4.19; P < .001), have milder severity score (OR = 0.62; 95% CI, 0.49-0.79; P < .001), and have higher <superscript>131</superscript> I uptake (OR = 2.40; 95% CI, 1.75-3.28; P < .001). In contrast, cats remaining persistently hyperthyroid were more likely to be younger (OR = 0.81; 95% CI, 0.72-0.92; P < .001), have higher severity score (OR = 1.87; 95% CI, 1.51-2.31; P < .001), and have lower <superscript>131</superscript> I uptake (OR = 3.50; 95% CI, 1.8-6.80; P < .001).<br />Conclusions and Clinical Importance: Age, sex, serum TSH concentration, bilateral and homogeneous <superscript>99m</superscript> Tc-pertechnetate uptake on scintigraphy, severity score, and percent <superscript>131</superscript> I uptake are all factors that might help predict outcome of <superscript>131</superscript> I treatment in hyperthyroid cats. Cats with persistent hyperthyroidism had many predictive factors that directly contrasted those of cats that developed <superscript>131</superscript> I-induced hypothyroidism.<br /> (© 2021 The Authors. Journal of Veterinary Internal Medicine published by Wiley Periodicals LLC on behalf of American College of Veterinary Internal Medicine.)
Details
- Language :
- English
- ISSN :
- 1939-1676
- Volume :
- 36
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Journal of veterinary internal medicine
- Publication Type :
- Academic Journal
- Accession number :
- 34817910
- Full Text :
- https://doi.org/10.1111/jvim.16319